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dence, to promotion of relapse in chronic users. Paradigms investigating the suppression of
actions have been investigated in animal and human research on drug addiction. Rodent
research has focused largely on impulsive behaviors, often gauged by premature respond-
ing, as a viable model highlighting the relevant role of dopamine and other neurotrans-
mitters primarily in the striatum. Human research on action inhibition in stimulant
dependence has highlighted impaired performance and largely prefrontal cortical abnorm-
alities as part of a broader pattern of cognitive abnormalities. Animal and human research
implicate inhibitory difﬁculties mediated by fronto-striatal circuitry both preceding and as
a result of excessive stimulus use. In this regard, response-inhibition has proven a useful
cognitive function to gauge the integrity of fronto-striatal systems and their role in
contributing to impulsive and compulsive features of drug dependence.
This article is part of a Special Issue entitled SI:Addiction circuits.
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The ability to suppress inappropriate behaviors is a hallmark
of executive functions, and essential for adaptive control of
everyday behavior. The psychological construct of response-
inhibition has been applied broadly in several contexts but
particularly to the psychological functions pertaining to over-
riding a planned action, or stopping a repetitive maladaptive
behavior (Bari and Robbins, 2013). Investigations of res-
ponse-inhibition have, to date, yielded important insights for
understanding addiction disorders. Such insights into the
psychological and neural processes mediating response-
inhibition not only provide more reﬁned models of drug
dependence and behavioral addiction but also inform
mechanism driven targets for future therapies. We focus
largely on stimulant drug dependence as much of the
impetus for research in this area has arisen from the study
of animal models with translational relevance. We will
initially provide a non-exhaustive survey of this ﬁeld before
focusing on translation to human drug abusers.2. Response-inhibition: Translation from
animal models
The psychological construct of response-inhibition has been
inﬂuential in at least two aspects of the animal literature
pertaining to the neurobiology of drug addiction. Both impul-
sivity and compulsivity require the notion of response-
inhibition. Impulsivity can be deﬁned as risky or premature
behavior, for example when it is necessary to wait for the
appropriate signal to perform a prepared response, whereas
compulsivity can be deﬁned as maladaptive preservative
behavior (Dalley et al., 2011). Drug abuse and dependence is
associated in humans with an impulsive, risk-taking ten-
dency, and one form of impulsivity has also been associated
with the tendency to exhibit binge intake of cocaine in rats
(Dalley et al., 2007). Speciﬁcally, rats exhibiting high levels of
premature responding in the 5-choice serial reaction time
test of sustained attention also exhibit (i) reduced D2/3
receptor binding in the ventral striatum (Dalley et al., 2007),
and (ii) altered grey matter in the nucleus accumbens core
region (Caprioli et al., 2014). The fact that the impulsive
behavior occurs prior to cocaine exposure suggests the possi-
bility that at least some impulsivity is not simply caused by
drug abuse but can also be antecedent to it (i.e. impulsivity is
an ‘endophenotype’, see below).
The most parsimonious explanation of this deﬁcit is that
behavioral inhibition impairment is caused by a malfunction-
ing nucleus accumbens. However, other data indicate that
the role of the nucleus accumbens in modulating this
premature responding is inﬂuenced by both ‘top-down’ and
‘bottom-up’ neural inﬂuences: structures contributing to ‘top-
down’ control include the infralimbic cortex and cingulate
cortex (Chudasama et al., 2003) whereas the ascending 5-HT
and noradrenergic pathways contribute to ‘bottom-up’, mod-
ulatory regulation (Economidou et al., 2012). Evidence for the
noradrenergic inﬂuence is provided by the ameliorative
effects of the selective noradrenaline reuptake inhibitoratomoxetine, whether either administered systemically or
when infused into the nucleus accumbens shell region
(Economidou et al., 2012).
The high impulsive rats also show impairments of impul-
sive choice; that is, they consistently choose small immediate
food rewards rather than larger, delayed ones (Robinson
et al., 2009), similarly to rats with excitotoxic lesions of the
nucleus accumbens core (Cardinal et al., 2001). However, the
possibility of a generalized response inhibitory deﬁcit in these
high impulsive rats is negated by the fact that they do not
have slower stop-signal reaction times in the stop-signal task
(SST) measuring a different type of impulsivity (Robinson
et al., 2009), which may be mediated by dorsal striatal rather
than ventral striatal mechanisms (Eagle et al., 2008; Eagle and
Baunez, 2010).
This work on impulsivity is also relevant to research on
relapse, where exposure to drugs, stress or conditioned
stimuli may elicit drug-taking and drug-seeking behavior
(Stewart, 1984). There are obvious parallels to the work on
impulsivity as shown by evidence that (i) atomoxetine also
reduces the reinstatement of cocaine—taking in rats follow-
ing punishment-induced abstinence (Economidou et al., 2012)
and (ii) a rich literature indicates a prominent role of the
rodent infralimbic cortex in the reinstatement of drug-
seeking behavior after its extinction (Kalivas and McFarland,
2003; Peters et al. 2008). Presumably both impulsivity and
reinstatement result in part from behavioral disinhibition.3. Reinstatement of drug-seeking behavior in
rodents
The classic phenomenon is the reinstatement of drug-
seeking behavior following its extinction by stress, drug
primes or conditioned stimuli (Shaham et al., 2003). The
paradigm has been criticized for its lack of translational
validity, given that extinction of human drug-taking does
not usually occur. Rather, drug-taking is customarily sup-
pressed by punishment (e.g. prison) or voluntary abstinence.
However, each of these situations implicates response inhi-
bitory processes—extinction, punishment and volitional con-
trol, and it is intriguing to consider whether they are
mediated by common, or at least, overlapping circuitry, such
as can be revealed by functional imaging studies in humans
(see below). An obvious problem in attempting this transla-
tion is the exact homological parallels that may exist for
human and rodent prefrontal cortical circuitry. Whereas, for
example the ventrolateral prefrontal cortex (PFC) is com-
monly implicated in self-control in humans, it is notoriously
difﬁcult to ﬁnd the rodent homologue of this structure;
whether it would reside in the rodent medial PFC ‘column’
or alternatively, in the more lateral orbitofrontal cortex, is
difﬁcult to ascertain.
For drug-primed relapse in rodents, manipulations of the
ventromedial PFC, such as inactivation by a mixture of GABA-
A and GABA-B agonists (muscimol and baclofen), identify the
prelimbic cortex to be the major controlling inﬂuence over
the nucleus accumbens core, which, again, appears to be a
key structure that drives the disinhibited drug-seeking beha-
vior (Kalivas and McFarland, 2003). Moreover, infusions of a
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reinstatement, somewhat paralleling evidence that infra-
medial PFC infusions of a 5HT-2A receptor antagonist block
high levels of impulsive responding on the 5-choice task
(Winstanley et al., 2004), above.
5-HT mechanisms are involved in the regulation of gluta-
mate release and the latter has been a focus of possible
therapeutic intervention to prevent relapse, for example with
N-acetylcysteine, a cysteine pro-drug that indirectly increases
extracellular glutamate (Zhou and Kalivas, 2008; Amen et al.,
2011) and modaﬁnil, an atypical stimulant drug that also
reduces the reductions of glutamate that normally occur
during relapse (Mahler et al., 2014). Recent work increasingly
implicates glutamate mechanisms within the nucleus
accumbens as a possible target for therapeutic agents such
as mGluR agonists. Other elicitors of relapse such as condi-
tioned cues, perhaps unsurprisingly, involve additional cir-
cuitry, for example, related to discrete conditioned and
contextual cues (basolateral amygdala and hippocampus)
and stress (bed nucleus of the stria terminalis), although it
is likely that prefrontal inhibitory control mechanisms
remain important also. However, there may be differences
among drug classes (including opiates and alcohol, as well as
stimulants see Bossert et al., 2013) and so it would be unwise
at this point to claim that a restricted set of medial PFC
projections mediate global forms of inhibitory response
control.
An additional source of complexity is provided by models
of compulsive drug-seeking, which can be gauged most
readily when self-administration behavior proceeds despiteFig. 1 – Panel 1a. Schematic representation of a single trial in the
food magazine. Following an intertrial interval (ITI), a brief light a
poke response in the appropriate hole in order to subsequently c
responds with a nose poke during the ITI rather than waiting (1).
hole (2) and preservative responding occurs when it continues to
representation of a sequence of trials in the go/no-go task. Subj
responses to another set (‘B’). Commission errors occur when s
representation of a sequence of trials in the stop signal task. Su
trial. On a minority of trials a stop signal (in this case a visual ‘X
signal (SS) delay is varied so is the resulting probability of succe
respond to a go stimulus by selecting the wrong key (5). By using
on go trials as well as the proportion of successful inhibitions an
can be calculated (stop signal reaction time).obvious adverse consequences, such as punishment by elec-
tric foot-shock (Belin et al., 2008; Pelloux et al., 2012). Pre-
sumably such behavior also entails a change in response-
inhibition processes probably mediated by PFC structures.
Given that compulsive behavior implicates orbitofrontal
(OFC)-striatal rather than medial PFC mechanisms (see
Dalley et al., 2011), it would appear that the control of relapse
and compulsive drug-seeking may be governed by different
neural systems, although probably organized along the same
general lines of top-down prefrontal control over striatal
outﬂow.4. Response-inhibition in human research
Response-inhibition in human research is relevant to many
tasks requiring executive control, which in turn encompasses
a more abstract inhibitory psychological construct in addition
to cognitive ﬂexibility and updating of working memory
(Miyake et al., 2000). In this regard, response-inhibition has
at times been considered to contribute to reversal learning
and Stroop performance, which involve additional complex
processes related to reward sensitivity, cognitive ﬂexibility,
rule learning and conﬂict resolution (Jentsch et al., 2014).
Response-inhibition speciﬁcally has proven useful as mea-
sured by a relatively standardized set of paradigms that
translate from experimental models and enable convergence
across levels of analysis. These range from non-invasive
and invasive imaging techniques in patients to lesion and
pharmacological manipulations (Bari and Robbins, 2013;5-CSRT task. The rat begins the trial with a nose poke in the
ppears in one of the apertures and the rat must make a nose
ollect its reward. Premature responding occurs when the rat
Error responding occurs when the rat responds to the wrong
respond rather than collect its reward. Panel 1b. Schematic
ects respond to one set of stimuli (‘A’) while withholding
ubjects respond to no-go stimuli (4). Panel 1c. Schematic
bjects respond to go stimuli (‘A’ and ‘B’) presented on each
’) indicates the prepotent response is to be withheld. As stop
ssfully inhibiting a response (6). Errors occur when subjects
a race horse model in combination with mean reaction time
d SS delay, an estimate of the latency to inhibit responding
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monly been investigated using go/no-go (GNG) and stop-
signal tasks (SST) which, though not identical, overlap con-
siderably (Eagle and Baunez, 2010). In both tasks, going
becomes prepotent by having prevalent speeded responses
and infrequent no-go or stop stimuli. In GNG tasks, subjects
respond to go stimuli whilst withholding responses to
another set of no-go stimuli, yielding the key measure of
commission errors, somewhat akin to premature responding.
In the SST, subjects are encouraged to respond to go stimuli
on all trials. However, these go stimuli are sometimes
immediately followed by a stop stimulus indicating the
planned response should be countermanded. The key mea-
sure of stop signal reaction time is derived by implementing a
race-model (Logan, 1994). Other primary measures include
execution latency and accuracy. Indices of error monitoring
and strategic adjustments can also readily be derived Fig. 1.
Considerable evidence implicates fronto-striatal circuits in
response-inhibition, particularly as measured by GNG and SST
(Bari and Robbins, 2013; Chambers et al., 2009). Prefrontal
cortical involvement is robustly supported by human research,
involving lesion, imaging, transcranial magnetic stimulation
and electrocorticography data (Aron et al., 2003; Swann et al.,
2012, 2011). The ﬁndings point to a circuit including the pre-
supplementary motor area (SMA) in the dorsomedial PFC
(dmPFC), and the anterior insula and inferior frontal gyrus in
the ventrolateral PFC (vlPFC), particularly on the right (Floden
and Stuss, 2006; Levy and Wagner, 2011). Subcortical involve-
ment in response-inhibition involves direct and indirect loops
in the striatum to the globus pallidus in addition to a parallel
pathway via the subthalamic nucleus (STN) outputting to
thalamocortical projections (Chambers et al., 2009; Eagle
et al., 2008) (Fig. 2). Pharmacological manipulations in humansFig. 2 – Schematic representation of circuitry involved in
response inhibition including interactions between cortical
areas as well as interactions with basal ganglia structures
projecting via the thalamus back to the prefrontal cortex. M1
primary motor cortex; dmPFC dorsomedial prefrontal cortex
(including the supplementary motor area); vlPFC
ventrolateral prefrontal cortex (including the anterior insula
and inferior frontal gyrus); ACC anterior cingulate, Globus
pallidus pars externa GPe; Globus pallidus pars interna/
reticular substantia nigra GPi/SN; subthalamic nucleus STN.as in rodents have highlighted dopamine and noradrenaline
involvement (Bari and Robbins, 2013; Eagle et al., 2008). Fronto-
striatal loops involving the OFC and vmPFC do not appear to be
primarily involved in suppressing inappropriate actions in
such paradigms (Robbins et al., 2012), although their links
to response-inhibition can be gauged in large scale studies
(Whelan et al., 2012). In the remainder of the review, unless
otherwise speciﬁed, we will use the term ‘fronto-striatal
regions’ to describe those areas speciﬁcally involved in
response-inhibition.
Over time, a reﬁned model of response-inhibition has
evolved acknowledging the relevance of multiple cognitive
processes in GNG and SST. Thus, attentional monitoring and
salience processing contribute to inhibitory performance with
the inferior frontal junction together with parietal areas likely
playing a role in detecting infrequent but behaviorally rele-
vant stimuli (Luijten et al., 2014; Swick et al., 2011). Addition-
ally, regions such as the dorsolateral PFC (DLPFC) are involved
in rule and goal maintenance (Dosenbach et al., 2007). These
tasks nevertheless engage a relatively narrow, overlapping
and well-deﬁned set of cognitive processes, providing a
useful platform to explore more subtle control functions
(Harle et al., 2014).5. Response-inhibition and stimulant
dependence
The rationale for investigating response-inhibition in stimu-
lant dependent individuals (SDI) is clearly manifold. First and
foremost, the symptoms manifested feature many aspects of
impaired self-control and difﬁculties in inhibiting inappropri-
ate behaviors. It is this loss of control that leads to persistence
in drug-taking with larger amounts consumed for longer than
intended, despite a desire to quit and despite adverse personal
and social consequences (American Psychiatric Association,
2000). As noted above, motor disinhibition contributes to key
aspects of impulsivity, as a core multifaceted construct pro-
moting addiction (Dalley et al., 2011). Response-inhibition
contributes to compulsivity, which is potentially orthogonal
but also relevant to substance abuse (Lubman et al., 2004). In
humans compulsivity is characterized by repetitive and ritua-
listic behaviors underscored by habit learning (Fineberg et al.,
2014; Robbins et al., 2012). How increased compulsivity may
contribute to the development of abuse is not presently well
understood, but compulsivity becomes more prominent with
chronic abuse as top-down control is continuously weakened
and dorsal striatum-mediated habitual control becomes domi-
nant (Everitt and Robbins, 2005, 2013). Beyond its speciﬁc and
direct involvement in addiction, the neurocognitive substrates
mediating response-inhibition also underlie aspects self, emo-
tion and social regulation (Tabibnia et al., 2011; Volkow et al.,
2011). Moreover, catecholamine regulation in these circuits is
compromised in addiction (Goldstein and Volkow, 2011).
In accordance with such reasoning, many contemporary
theories emphasize disrupted inhibitory control in drug use
in combination with impulsive decision making and altered
motivational and reward processes (Dalley et al., 2011;
Goldstein and Volkow, 2011; Li and Sinha, 2008; Verdejo-
Garcia et al., 2008). Disruptions to control processes
b r a i n r e s e a r c h 1 6 2 8 ( 2 0 1 5 ) 1 1 7 – 1 2 9 121contribute to multiple components of addiction such as
increasing susceptibility to initial use, transition to depen-
dence, maintenance, as well as contributing to relapse and
difﬁculties in maintaining abstinence (Perry and Carroll,
2008).
There is broad agreement that response-inhibition is
impaired in SDI (e.g., Li and Sinha, 2008; Luijten et al., 2014;
Perry and Carroll, 2008; Spronk et al., 2013). Below we outline
some main ﬁndings before considering emerging trends and
issues. When discussing aberrant task performance and poten-
tial mediating neural substrates in SDI, key questions pertain to
their causal role, their presence as a result of neurotoxic effects,
or as an interaction between the two (Perry and Carroll, 2008).
One approach is to examine available evidence in a framework
outlining the temporal evolution of drug use, from prior to
initial use to following chronic abuse, and in those who try to
abstain: withdrawal, abstinence and at times, relapse.
Only a handful of papers have investigated response-
inhibition in children or adolescents at risk for abuse for
any substance. This is despite evidence from other paradigms
of inhibitory control suggesting response-inhibition as a
likely indicator of neurobiological risk for substance use
disorders (Ivanov et al., 2008). In adolescents at risk for
alcohol use disorders, stopping performance predicted not
only alcohol-related problems but also illicit drug use inde-
pendently of familial risk and attention deﬁcit hyperactivity
disorder (ADHD) and conduct disorder problems (Nigg et al.,
2006). This evidence dovetails with another study where
neurobehavioral disinhibition did not include response-
inhibition measurements (Tarter et al., 2003, 2004). Another
approach has been to survey a large sample of adolescents,
capturing the range of possible precursor behaviors or ‘beha-
vioral endophenotypes’. Evidence from the IMAGEN project
indicated that although adolescents who tried illicit sub-
stances did not differ in stopping performance from those
who did not, they did exhibit higher activation in a right
frontal network comprising vlPFC and ACC, thereby requiring
greater brain activity levels to produce similar inhibitory
performance (Whelan et al., 2012). Without longitudinal
follow-up, it is unclear what portion of at risk groups went
on to develop substance use disorders (but see Whelan et al.,
2014, for initial longitudinal data).
A more substantial body of evidence speaks to worse
response-inhibition performance in SDI with a mixed pattern
for response execution. (Ersche et al., 2011, 2012a; Fillmore
and Rush, 2002; Hester and Garavan, 2004; Lane et al., 2007;
Morein-Zamir et al., 2013; Morie et al., 2014a). Functional
magnetic resonance imaging (fMRI) studies have generally
reported reduced PFC activation accompanying response-
inhibition difﬁculties, with hypoactivation of vlPFC and at
times medial, cingulate, and DLPFC in addition to cerebrellar
hyeractivation (Hester and Garavan, 2004; Kaufman et al.,
2003; Morein-Zamir et al., 2013). The ﬁndings appear consis-
tent despite differences across studies in the contrast used to
isolate response-inhibition, and key procedural differences
such as working memory load. Together, such converging-
operations support the reliability of the accompanying
hypoactivation. When considering brain structure, white
matter integrity in key regions such as the vlPFC correlated
with the response-inhibition performance in SDI, whilst nosuch robust relationships with grey matter volume were
apparent (Ersche et al., 2012a). Although impairment is found
consistently, its association with disorder severity measures
is small and inconsistent. This is in keeping with other
ﬁndings showing that executive dysfunction, as measured
by laboratory tasks, is not necessarily associated in a straight-
forward manner with increased drug use (Morie et al., 2014a;
Verdejo-Garcia and Perez-Garcia, 2007).
The relatively few reported abnormalities in the striatum
may seem surprising given its role in response-inhibition and
in mediating addiction in animal research. However, this is
likely due to fMRI studies largely utilizing tasks that do not
efﬁciently model response execution processes separately from
baseline. Future studies may consider the beneﬁts of introdu-
cing sequences that allowmore sensitive assessment of striatal
involvement. Additionally, evidence for anatomical striatal
abnormalities in SDI has been particularly inconclusive, possi-
bly due to its susceptibility to individual differences in recent
history of abuse and/or abstinence (Ersche et al., 2013c).
Acute administration of cocaine or intravenous methylphe-
nidate has led to improved response-inhibition performance in
active or recently abstinent SDI (Fillmore et al., 2002, 2006;
Garavan et al., 2008; Li et al., 2010), and occasionally also in
response execution performance (Garavan et al., 2008). Concur-
rent fMRI indices indicate increased activation in the striatum,
thalamus and PFC regions that are typically hypoactive in active
users (Garavan et al., 2008; Li et al., 2010). This is consistent with
a consensus that acute cocaine ameliorates or masks existing
executive impairments (e.g., Woicik et al., 2009).
Given that inhibitory control probably plays a role in
abstinence and relapse avoidance, it is signiﬁcant that absti-
nent SDI show less robust patterns of impairment, suggestive
of possible recovery or compensation. After short term to
intermediate cessation of use (up to several weeks), response-
inhibition appears impaired in some studies (Li et al., 2006b;
Monterosso et al., 2005) but not others (Li et al., 2008; van der
Plas et al., 2009). Response execution was not reported as
signiﬁcantly worse demonstrating a degree of speciﬁcity. Simi-
larly, accompanying PFC hypoactivation appears less robust
with reduced anterior cingulate (ACC) activation reported
(Li et al., 2006b). Reduced vlPFC grey matter volume, worse
inhibitory performance but no response execution differences
was reported in abstinent methamphetamine users (Tabibnia
et al., 2011). Evidence regarding performance in longer term
abstinent users has been even more scarce in part due to
the challenges of conducting such studies, which typically
encompass a range of abstinence durations. Disruptions in
response-inhibition were noted in some studies (Fernandez-
Serrano et al., 2012) but not others (Bell et al., 2014a, 2014b;
Verdejo-Garcia et al., 2006), with again a mixed pattern for
response execution. Though one small study reported hyper-
activation of some PFC regions (Connolly et al., 2012) this was
not replicated subsequently (Bell et al., 2014a, 2014b). Electro-
physiological aberrations during response-inhibition have also
been reported (Franken et al., 2007; Morie et al., 2014b).
However, the relationship between inhibitory control and such
measures is complex and understanding their signiﬁcance is
still evolving (Huster et al., 2013).
In summary, the evidence points to response-inhibition
deﬁcits accompanied by reduced PFC recruitment in current
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normalize to some degree with abstinence. This conclusion is
highly consistent with evidence from other forms of cognitive
control in SDI involving fronto-striatal systems (Feil et al.,
2010; Jovanovski et al., 2005). There remains a dearth of
information regarding long-term abstinence and the role
response-inhibition per se might play in its promotion,
though if a preexisting vulnerability factor, it could be
relatively unaffected by present state. This notion is consis-
tent with evidence from other substance use disorders where
response-inhibition appears unrelated to abstinence and
treatment retention (Stevens et al., 2014). Alternatively, suc-
cessful abstinence may involve active strengthening of inhi-
bitory control, so that impairment in long-term successful
abstainers may be paradoxically reduced compared to high-
risk individuals. It remains unclear how precisely response
disinhibition may serve as a risk factor for relapse though the
mediating neural structures have been reported to be modu-
lated by abstinence (Garavan et al., 2013).
Based on evidence from SDI cross-sectional studies, the
degree to which neurobiological fronto-striatal abnormalities
predate or follow stimulant abuse is unclear, though ﬁndings
from at risk individuals indicate both are in play. Given the
temporal evolution of addiction, it is only the difﬁculty of
conducting longitudinal and prospective studies that has
prevented their more pervasive use to help disentangle
causal associations between cognition and drug use. None-
theless, several such projects are set to shed light on how
response-inhibition as part of a larger set of top-down control
functions may typify stimulant use over time. Finally, it is
possible that response-inhibition deﬁcits, which progres-
sively grow with age (Williams et al., 1999), may contribute
even further to general impairment with increased cumula-
tive use, consistent with evidence suggesting the deleterious
effects of aging are accelerated in drug users (Ersche et al.,
2013a).6. Addressing the relationship between
disinhibition and stimulant dependence
Relevant to the issue of the extent to which response-
inhibition deﬁcits predispose or result from stimulant depen-
dence, are two additional lines of evidence. First, is the
investigation of not only SDI but also their biological ﬁrst
degree siblings to detect common vulnerability markers.
The notion that response-inhibition might prove a useful
endophenotype, mediating genes and clinical symptoms
(Gottesman and Gould, 2003) is plausible given that executive
functions and brain structure are highly heritable (Friedman
et al., 2008; Thompson et al., 2001), as is stimulant dependence
(Merikangas and McClair, 2012). Closer inspection of character-
istics unique to the unaffected siblings compared to the SDI
and controls may also highlight protective or compensatory
mechanisms (Morein-Zamir et al., 2013). Thus, response-inhi-
bition performance in unaffected siblings has been reported as
impaired compared to controls, acting as a shared trait in the
sibling pairs (Ersche et al., 2012a). Moreover, response-
inhibition performance was associated with white matter
vlPFC abnormalities commonly shared in the sibling pairs(Ersche et al., 2012a). This shared vulnerability did not extend
however to reduced prefrontal activation in the siblings, who
demonstrated increased rather than decreased recruitment of
key PFC regions including the pre-SMA (Morein-Zamir et al.,
2013). The overall complex shared and distinct pattern of brain
structure, personality traits and cognitive abnormalities sup-
port response-inhibition difﬁculties as being one of the most
robust cognitive vulnerabilities predisposing to the develop-
ment of stimulant drug dependence.
A second line of evidence is the investigation of recrea-
tional cocaine users, loosely identiﬁed by self-reported regular
cocaine use, without fulﬁlling DSM-IV criteria. Response-
inhibition disruptions were reported in recreational users in
one small study (Colzato et al., 2007) though not in others
(Harle et al., 2014; Vonmoos et al., 2013b), raising the question
of whether adverse disinhibitory effects of regular stimulant
use are inevitable. In another study, intact performance was
accompanied by increased dmPFC and ACC activation suggest-
ing inefﬁcient neural recruitment (Morein-Zamir et al.,
submitted). Broader neurocognitive ﬁndings and self-reported
impulsivity demonstrate similar patterns, with some studies
indicating only subtle effects in recreational users (Ersche
et al., 2013b) whilst others indicate them to be intermediate
between controls and SDIs (Hulka et al., 2013; Vonmoos et al.,
2013a, 2013b). Recreational users, as SDI, consistently exhibit
elevated sensation seeking (Mackey et al., 2014), a trait absent
in unaffected siblings of SDI (Ersche et al., 2010), suggesting its
orthogonality to response-inhibition. As recreational users
typically present with fewer years and less cumulative use
than SDIS, any differences might merely be due to presenta-
tion along different stages of the dependence trajectory (Preller
et al., 2013). Alternatively, some recreational users may com-
prise a separate neurobiological phenotype, with normative
cognitive, impulsivity and compulsivity levels along with
increased rather than reduced OFC grey matter characteristic
of SDI (Ersche et al., 2013b). Together with reports of controlled
long-term usage and high intelligence, this suggests a resilient
subgroup, in which any deleterious effects of repeated drug
exposure are subtle. Increased characterization of potentially
resilient individuals could inform not only therapeutic strate-
gies but also enable more accurate animal models allowing
better linkage to genetic and molecular mechanisms (Ersche
et al., 2013b). However, with no consistent characterization of
recreational or occasional users across studies, integrating
ﬁndings remains a challenge.
Taken together, the ﬁndings elucidate how disruptions in
response-inhibition contribute via multiple pathways to
drug dependence. High impulsivity, manifested in part by
impaired inhibition, hypothetically facilitates initial exposure
and subsequent escalation, whilst elevated sensation seeking
contributes only to the former. Elevated compulsivity likely
contributes in parallel. Evidence that high impulsivity and to
some extent compulsivity may predate drug use, is evidenced
in the unaffected biological siblings (Ersche et al., 2012b). Age
at onset of exposure comprises another critical factor, as
response-inhibition is undergoing development when initial
experimentation with drugs often occurs in SDI, whilst
recreational users often experiment at a later age. Impaired
response-inhibition in SDI may also contribute to maladap-
tive patterns of use, such as bingeing. In contrast, preserved
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trolled and sustainable usage, providing a degree of protec-
tion from the adverse consequences of protracted drug use.
Inefﬁcient recruitment of key fronto-striatal regions mediat-
ing response-inhibition is evident in the unaffected siblings,
the recreational users and in adolescents reporting what
could be construed as preliminary exposure (Morein-Zamir
et al., 2013; Whelan et al., 2012). This suggests fronto-striatal
systems can compensate for some level of vulnerability or
compromise to the system, whether from preexisting sus-
ceptibility or preliminary drug exposure. Evidence from other
disorders also suggests compensatory recruitment in key
dmPFC regions associated with response-inhibition (de Wit
et al., 2012). However, with increasing usage or greater
vulnerability compensation is no longer possible, resulting
in reduced neural recruitment and disrupted performance.
Numerous studies have also indicated excessive cerebellar
recruitment during response-inhibition in impulsive groups
including SDI (Connolly et al., 2012; Hester and Garavan, 2004;
Rubia et al., 2013; White et al., 2014). Both unaffected siblings
and recreational users share increased cerebellar grey matter
density (Ersche et al., 2013b). Thus, complementary compen-
satory routes may exist when fronto-striatal mediation of
response-inhibition becomes sufﬁciently compromised.7. A broader view of disinhibition and
stimulant dependence
Despite a superﬁcially coherent picture, several issues merit
discussion within the broader context of cognition and addic-
tion models. First, chronic stimulant use has been associated
with disruptions, not only in response-inhibition, but across a
broad set of cognitive domains associated with fronto-striatal
systems such as planning, working memory, decision-making
and attention (Fernandez-Serrano et al., 2011; Jovanovski et al.,
2005). Effect sizes are typically moderate and in this regard
response-inhibition may serve as a representative assay of
fronto-striatal integrity mediating top-down executive control
(Friedman et al., 2008). Nevertheless, it is evident that impul-
sivity, compulsivity and executive function are fractionated and
complex (Dalley et al., 2011; Miyake et al., 2000). Thus it may be
of use in future to extend their ecological validity by examining
how combining multiple constructs, such as response-
inhibition and impulsive choice, may contribute to drug depen-
dence symptomatology, as evidenced in other clinical popula-
tions (Solanto et al., 2001).
Another issue is polysubstance use, which is an inherent
part of the common SDI phenotype (Pennings et al., 2002).
Response-inhibition performance is likely disrupted in alcohol
dependence and possibly nicotine dependence per se, at least
under conditions of withdrawal, though it is unclear again
whether disruptions are speciﬁc to response-inhibition
(Fillmore and Vogel-Sprott, 1999; Goudriaan et al., 2006;
Kozink et al., 2010; Monterosso et al., 2005; Mulvihill et al.,
1997; Nederkoorn et al., 2009). This raises the possibility that it
is disrupted across various substance dependence categories,
along with mediating fronto-striatal circuitry interferences.
Alternatively, it has been proposed that stimulants and alcohol
have a more speciﬁc effect on impulsive action, includingresponse-inhibition, compared to other drugs (Fernandez-
Serrano et al., 2011). Research on pure recreational stimulant
users or on suitable animal models may help disentangle the
effects of stimulants in relation to alcohol and nicotine.
Response-inhibition difﬁculties are also apparent across a
broad spectrum of neuropsychiatric conditions (Robbins
et al., 2012). Moreover, SDIs are characterized by a high rate
of comorbid personality and mood disorders (Cheetham et al.,
2010). ADHD is particularly of interest to addiction research
given shared ateological inﬂuences, common dopaminergic
involvement, and overlapping fronto-striatal abnormalities,
such as vlPFC hypoactivation associated with impaired
response-inhibition (Hart et al., 2013). Children with ADHD
are also signiﬁcantly more likely to develop substance use
disorders (Lee et al., 2011). Increased impulsivity, manifested
in part by impaired response-inhibition and common to both
groups, drives the similarities as they are evident in each
patient group without comorbidities (Morein-Zamir et al.,
2013, 2014). Disruptions to the fronto-striatal circuits can also
be found in disorders of excessive compulsivity such as OCD
and trichotillomania and ﬁrst-degree relatives of the former
(Chamberlain et al., 2007b, 2007c). In fact, we anticipate that
any disorder characterized by executive function weakness
and disrupted fronto-striatal circuity should demonstrate
performance disruptions in response-inhibition, as in Parkin-
son’s disease and Tourette’s disorder (Gauggel et al., 2004;
Goudriaan et al., 2006; van den Wildenberg et al., 2006). Some
speciﬁcity is apparent as such difﬁculties have not been
found in anxiety disorders (Lipszyc and Schachar, 2010).
Research to date has not revealed a strong link between
response-inhibition as measured in GNG and SST per se and
OFC and vmPFC integrity, despite both regions being implicated
in compulsivity (Milad and Rauch, 2012) and addiction (Koob
and Volkow, 2010). Turning to OCD as a key disorder of
compulsivity, both OCD patients and SDI are characterized by
increased ritualistic, time consuming compulsive behaviors,
where OFC abnormalities are considered key (Meunier et al.,
2012; Rotge et al., 2008). OFC and dorsomedial striatum integrity
is implicated in mediating cognitive ﬂexibility and suppressing
a previously rewarded response in favor of an alternative
(Chamberlain et al., 2008; Jentsch et al., 2014). Reduced OFC
grey matter density and metabolism is found in SDI and, in
early adolescents, is predictive of subsequent illicit substance
use (Cheetham et al., 2010; Whelan et al., 2012, though see
Montigny et al., 2013). OFC and vmPFC circuits could mediate
complementary mechanisms underlying dependence sympto-
matology, such as rigidity, perseverative responding and
increased habit formation (Jentsch et al., 2014; Voon et al.,
2014). Whether response-inhibition contributes in some indirect
manner to dysfunction in these seemingly independent
mechanisms, or interacts with them is an open question,
although the interconnectedness of fronto-striatal circuits sug-
gests this possibility (Milad and Rauch, 2012).8. Future directions
Response-inhibition is one of several complex interacting
processes such as impulsive choice, altered decision making,
salience attribution and motivational/reward and emotional
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(Cheetham et al., 2010; Goldstein and Volkow, 2011; Koob
and Volkow, 2010). Both human and rodent models of
response-inhibition and top-down control relevant to sub-
stance dependence are undergoing reﬁnement, as integration
from multiple lines of independent enquiry better approx-
imate phenotypic complexity. Inhibitory dyscontrol contri-
butes to substance dependence via increased impulsivity and
compulsivity and general executive function weakness con-
stituting overlapping routes, all undergoing changes due to
drug exposure and natural maturation. Given the progress in
understanding response-inhibition, it can serve as a particu-
larly useful and valid model of how maturation as well as
gender and genetic interactions inﬂuence fronto-striatal
mediated top-down control (Li et al., 2006a; Nymberg et al.,
2013; Rahman and Clarke, 2005; Rubia et al., 2013; White et al.,
2014). Disruptions of behavioral inhibition and executive
control are mechanisms through which lower socioeconomic
status (Hackman and Farah, 2009) and early stress may lead
to reported social difﬁculties (Volkow et al., 2011) and
increased likelihood of exposure to drug and transitions to
dependence. Thus, there is a need for integration of research
between top-down executive control, altered reward systems,
and motivational mechanisms, possibly relating to factors
such as negative urgency, affect and stress to inhibitory
control in substance dependence (Albein-Urios et al., 2013;
Cheetham et al., 2010; Li and Sinha, 2008). For example, how
does impulsive choice coupled with reduced response-
inhibition lead to symptoms? While each line of enquiry is
supported by a rich body of ﬁndings, examining how
response-inhibition during temporal unfolding of substance
dependence, is inﬂuenced by acute stress, changes in moti-
vation and affect can advance this goal and promote its
clinical relevance. The modulation of response-inhibition by
affect and motivation (Morie et al., 2014a; Pike et al., 2013)
may provide converging evidence to lines of enquiry into
cognitive control focusing on drug-related materials such as
the emotional Stroop (Smith et al., 2013).
How might better understanding of response-inhibition be
of relevance to treatment of SDI? From a conceptual standpoint,
cognitive difﬁculties, although largely of medium effect size,
may have pronounced consequences on daily functioning and
can negatively affect treatment outcome and prevention. Gen-
eral inhibitory control impairments tend to be associated with
poor treatment retention and increased dropout (Aharonovich
et al., 2008; Stevens et al., 2014). From a conceptual standpoint,
proposed therapies strengthening inhibitory function should
beneﬁt from the strong preclinical and cognitive neuroscience
evidence. Accordingly, cognitive behavioral therapy is believed
to lead to improvements at least in part by inﬂuencing execu-
tive functioning (Sofuoglu et al., 2013). Treatment approaches
could be allocated based on individual cognitive function also
accounting for the impulsive cognitive style characteristic of
SDI (Stevens et al., 2014). Applying pharmacological agents with
low abuse potential to improve cognitive functioning and
speciﬁcally response-inhibition could thus be doubly useful.
Recent studies have proposed that modaﬁnil may facilitate
clinical improvement during initial abstinence via blunting
cocaine-induced euphoria (Dackis et al., 2005) or normalizing
disrupted sleep patterns (Morgan et al., 2010). Improved top-down control may be another mechanism by which such
treatments may operate (Economidou et al., 2009). In healthy
individuals and in ADHD patients modaﬁnil and atomoxetine
have improved aspects of cognition, including response-
inhibition (Chamberlain et al., 2006, 2007a; Turner et al., 2003,
2004). In fact, atomoxetine, licensed for ADHD treatment, was
found to exert its beneﬁcial effects on response-inhibition via
modulation of the right vlPFC (Chamberlain et al., 2009). How-
ever, despite initial promise for modaﬁnil, it appears that
comorbid alcohol use as well as gender and concomitant
behavioral therapy may be important qualiﬁers for effective-
ness in relapse prevention (Anderson et al., 2009; Dackis et al.,
2012). Similarly, a recent study of atomoxetine in SDI found no
signiﬁcant improvement, although it is possible these patients
had already well-established habits (Walsh et al., 2013).
Present evidence regarding neurostimulation, either via
repetitive transcranial magnetic stimulation or transcranial
direct current stimulation, has focused on the DLPFC circuit
as a viable therapeutic procedure for improving symptoms such
as craving (Jansen et al., 2013). Evidence that pre-SMA or vlPFC
neurostimulation may improve response-inhibition is still pre-
liminary (Ditye et al., 2012; Jacobson et al., 2011), but could serve
as an additional therapeutic target. As the role of individual
differences is elucidated, impaired response-inhibition may
provide a well understood mechanism allowing for the predic-
tion of the best responders to such interventions, possibly in
combination with improved behavioral therapies.
The ﬁeld has beneﬁtted thus far from translational cross-
species paradigms, with response-inhibition constituting a key
element of the impulsivity construct. Use of such paradigms in
experimental animals is highlighting a fractionation of the
impulsivity construct in terms of fronto-striatal circuits
(Dalley et al., 2011) implying a different view of how response
inhibitory executive control is implemented. An important step
will now be to test this approach in humans, including SDI. For
example, Voon et al. (2014) recently showed in an analogue of
the rodent 5-choice task that methamphetamine abusers and
recreational cannabis users both exhibited higher levels of
impulsive responding. We predict that a combination of inves-
tigations in both experimental animals and in humans will be
required to fully understand the role of response inhibitory
impairments in stimulant dependence and addiction more
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